SynthesisDrugs2020

ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.

Yaru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.